在模拟目标试验中,他类药物和脊椎骨矿物质密度的纵向变化:动脉样硬化多民族研究
Elena Ghotbi1, Quincy A Hathaway2, Roham Hadidchi1
1Department of Radiology and Radiologic Sciences, Johns Hopkins University, Baltimore, MD, United States.
Bone
|September 24, 2025
概括
通过在6年内减缓脊椎骨矿物质密度 (BMD) 的下降,开始服用他可以保护骨健康. 这一发现表明,在高心血管风险的人群中,对骨健康有潜在的益处.
科学领域:
- 骨生物学和药理学 骨生物学和药理学
- 心血管疾病风险管理心血管疾病风险管理
- 老年学和衰老研究研究.
背景情况:
- 关于他类药物对骨健康的影响,有相互矛盾的报道.
- 人口异质性可能解释了先前研究中的差异.
- 评估他类药物启动对纵向骨密度的影响至关重要.
研究的目的:
- 评估六年来开始他类药物治疗与脊椎骨矿物质密度 (BMD) 变化之间的关联.
- 调查各种人口和临床因素的潜在修饰效应.
- 量化残留混,以验证发现.
主要方法:
- 使用多民族动脉样硬化研究 (MESA) 数据模拟的向试验.
- 包括具有高10年ASCVD风险和没有先前使用他类药物的参与者.
- 开始服用他类药物和不开始服用他类药物的倾向性得分匹配.
- 线性混合效应模型用于分析CT衍生的脊椎BMD变化 (T1-T10).
- 亚组分析和基于数组的混评估.
主要成果:
- 开始服用他类药物与脊椎骨质量每年下降的速度显著减缓 (0.47%减缓).
- 观察到的效应需要大量未测量的混才能被取消.
- 在患有糖尿病的参与者中,观察到更强的保护性关联,较低的hs-CRP和更高的体力活动.
结论:
- 开始使用他类药物表明与骨健康有积极的关联.
- 这些发现支持他类药物在维护骨密度方面的潜在作用.
- 进一步的研究可能会阐明机制并优化治疗策略.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
395
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
395
01:26Longitudinal Studies
479
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
479
01:20Study Designs in Epidemiology
897
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
897
01:29Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321